Sotera Health Co at Citi Healthcare & Medtech Conference Transcript
Okay. We can look to get started here, second day of the conference. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. Happy to have Michael, the CEO of Sotera, with us to kick off the day. Fresh off earnings, I think it was just Tuesday. A couple of days ago, you guys reported.
So maybe we can start there. Maybe just kind of walk through the highlights of the quarter, given how fresh it is. You guys gave the new guidance. So maybe start with the quarter and then we can work our way to kind of some of the moving pieces on the guidance.
Questions & Answers
Yes. Good quarter. Overall, the business is performing well. We finished out 2022 pretty well. Lots of dynamics, lots of moving parts between labor challenges, inflation and supply chain. But over-all it came in slightly better than we expected, but we're optimistic about what '23 is going to look like.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |